jaffeab Profile Banner
Aron Jaffe Profile
Aron Jaffe

@jaffeab

Followers
717
Following
762
Media
205
Statuses
2K

SVP @ https://t.co/5bCQBx9DVy;Former SVP Head of Research @chromamedicine;EIR @ThirdRockV;Reg Med, uBiome group leader/Resp DA co-lead @NovartisScience. Opinions mine

Boston, MA
Joined October 2011
Don't wanna be here? Send us removal request.
@jaffeab
Aron Jaffe
5 months
Our work describing the development of a potent epigenetic editor targeting human #PCSK9 for durable reduction of LDL-C is out in @NatureMedicine today!.Cc: @chromamedicine @nchromabio.1/9.
1
1
5
@jaffeab
Aron Jaffe
13 hours
RT @rtnarch: USA is strong because of the people, not the government. We are a nation of individuals who either got thrown out or chose to….
0
7
0
@jaffeab
Aron Jaffe
13 hours
How we’re rebuilding the Weizmann Institute — and our hopes for a better future
0
0
0
@jaffeab
Aron Jaffe
20 days
Happy Father’s Day to @rcjaffe & all the Dads out there!. I dont @ him often, but 👇🏼 is one of my favorites.
@jaffeab
Aron Jaffe
5 years
My father @rcjaffe officially retired this week. His last day @UICPhysiology was Monday, 8/31. Although my Dad always described himself as ‘small potatoes’, and since there was no departmental send-off, I wanted to highlight a few things about his career (thread).
0
0
2
@jaffeab
Aron Jaffe
1 month
RT @Carolynyjohnson: In case you needed a smile this Tuesday: 10-month-old baby KJ, who received a bespoke gene-editing therapy after a six….
0
67
0
@jaffeab
Aron Jaffe
1 month
When a therapeutic approach works, it's on us as a global community to figure out how to get it to ALL patients in need. Great piece by @Jasonmmast . What Baby KJ means for the CRISPR gene editing industry via @statnews.
0
0
4
@jaffeab
Aron Jaffe
1 month
RT @statnews: The custom-built gene editing treatment for 6-month-old KJ Muldoon could not have come at a more welcome or jarring time for….
0
6
0
@jaffeab
Aron Jaffe
2 months
0
0
0
@jaffeab
Aron Jaffe
2 months
Absolutely amazing. Congratulations to @kiranmusunuru @UrnovFyodor & everyone involved.
@EricTopol
Eric Topol
2 months
Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism".—the 1st human to undergo custom genome editing.—outgrowth of decades of NIH funded research.@NEJM
Tweet media one
Tweet media two
0
0
1
@jaffeab
Aron Jaffe
2 months
FDA delays are bad in general, but for a small biotech they can be existential. Let’s hope this is an edge case.
0
1
2
@jaffeab
Aron Jaffe
3 months
Congrats to ⁦@skathire⁩ and the entire team ⁦@VerveTx⁩ . Big day for the field. Bigger day for patients
0
1
18
@jaffeab
Aron Jaffe
3 months
“The most effective way to prevent the spread of measles is the MMR vaccine”.
@SecKennedy
Secretary Kennedy
3 months
I came to­ Gaines County, Texas, today to comfort the Hildebrand family after the loss of their 8-year-old daughter Daisy. I got to know the family of 6-year-old Kayley Fehr after she passed away in February. I also developed bonds with and deep affection for other members of.
0
0
0
@jaffeab
Aron Jaffe
3 months
First game of the season with the boy. Never gets old.
Tweet media one
0
0
3
@jaffeab
Aron Jaffe
3 months
Congratulations @davidrliu!.
@broadinstitute
Broad Institute
3 months
David Liu receives Breakthrough Prize in Life Sciences. @davidrliu is honored for the development of base editing and prime editing, two gene editing technologies transforming medicine. @brkthroughprize
Tweet media one
0
0
5
@jaffeab
Aron Jaffe
4 months
RT @doctorveera: I and my colleague, Sahar Gelfman, at RGC had the privilege to write a News and Views article for @nature about a recent w….
0
41
0
@jaffeab
Aron Jaffe
4 months
@PeteBlackburn
Pete Blackburn
4 months
If anything cool actually came from this effort, this would be one of the sickest hockey photos ever
Tweet media one
0
0
1
@jaffeab
Aron Jaffe
4 months
0
0
0
@jaffeab
Aron Jaffe
4 months
This is a big day for patients with AATD and a big win for genomic medicine. Congrats to the entire Beam Team @BeamTx!.
@BeamTx
Beam Therapeutics
4 months
Today, Beam announced positive initial data for BEAM-302 from its Phase 1/2 trial in alpha-1 antitrypsin deficiency (AATD), establishing clinical proof-of-concept and demonstrating the first ever clinical gene editing correction of a disease-causing mutation.
Tweet media one
0
0
2
@jaffeab
Aron Jaffe
4 months
RT @davidrliu: Truth and wisdom at Boston #StandUpForScience
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
304
0
@jaffeab
Aron Jaffe
4 months
Completely preventable.
0
0
0
@jaffeab
Aron Jaffe
4 months
Congratulations to @bigosi @SethEttenberg & the entire @BlueRockTx team! . BlueRock Therapeutics receives FDA Fast Track Designation for OpCT-001 for the treatment of primary photoreceptor diseases 
0
0
1